Sirios intersects 10.3 g/t Au over 2.9 m on the Aquilon gold property, Eeyou Istchee James Bay, Quebec, Canada
MONTREAL, Sept. 22, 2020 (GLOBE NEWSWIRE) — Management of SIRIOS RESOURCES INC. (TSX-V: SOI) is pleased to announce assay results from […]
Influence+United welcomes Buzzoole
Naples, Italy, Sept. 22, 2020 (GLOBE NEWSWIRE) — Influence+United charter member, IZEA Worldwide, Inc. (NASDAQ: IZEA), today welcomed the leading […]
Brazil Approves RedHill Biopharma’s Phase 2/3 COVID-19 Study with Opaganib
The ongoing global Phase 2/3 study with orally-administered opaganib in patients with severe COVID-19 is approved in Italy, the UK, […]
Cartier presents the strong hoisting capabilities of the shaft on the Chimo Mine Property
Highlights:With simple adjustments, the shaft on the Chimo Mine Property could extract 1.7 million metric tons per year (4,921 mt/day).This […]
DTE Energy Company Announces Junior Subordinated Debentures Offering
Detroit, Sept. 22, 2020 (GLOBE NEWSWIRE) — DETROIT, Sept. 22, 2020 — DTE Energy Company (NYSE: DTE) announced today its […]
Vislink Technologies Retains KCSA Strategic Communications as Corporate Communications Counsel
HACKETTSTOWN, NJ, Sept. 22, 2020 (GLOBE NEWSWIRE) — Vislink Technologies, Inc. (“Vislink” or the “Company”) (Nasdaq: VISL), the global technology […]
Aequus Announces Expansion of Medicom Partnership and Filing with Health Canada for Additional Evolve Dry Eye Product
VANCOUVER, British Columbia, Sept. 22, 2020 (GLOBE NEWSWIRE) — Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), […]
DTE Energy and Consumers Energy pledge to help build extensive Midwest electric vehicle charging network
DETROIT and JACKSON, Mich., Sept. 22, 2020 (GLOBE NEWSWIRE) — DTE Energy and Consumers Energy have announced they are joining […]
TRULICITY® (dulaglutide) est indiqué comme traitement d’appoint à un régime alimentaire, à l’exercice et au traitement standard pour réduire le risque d’accident vasculaire cérébral non mortel chez les adultes atteints de diabète de type 2 qui présentent des facteurs de risque cardiovasculaires multiples ou une maladie cardiovasculaire établie
TORONTO, 22 sept. 2020 (GLOBE NEWSWIRE) — Le 11 septembre 2020, Santé Canada a approuvé l’utilisation de Trulicity® (dulaglutide) pour la réduction du […]
Trulicity® (dulaglutide) is now indicated as an adjunct to diet, exercise, and standard of care therapy to reduce the risk of non-fatal stroke in adults with type 2 diabetes mellitus who have multiple cardiovascular risk factors or established cardiovascular disease
TORONTO, Sept. 22, 2020 (GLOBE NEWSWIRE) — On September 11, 2020, Health Canada approved Trulicity® (dulaglutide) to reduce the risk […]
